Axon Enterprise, Inc $AXON Stock: Maryland State Retirement & Pension System Increases Position

Maryland State Retirement & Pension System boosted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 6,258.0% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 260,804 shares of the biotechnology company’s stock after buying an additional 256,702 shares during the quarter. Axon Enterprise makes up approximately 1.7% of Maryland State Retirement & Pension System’s holdings, making the stock its 7th largest holding. Maryland State Retirement & Pension System’s holdings in Axon Enterprise were worth $110,195,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Cabot Wealth Management Inc. increased its holdings in shares of Axon Enterprise by 11,781.7% during the third quarter. Cabot Wealth Management Inc. now owns 223,139 shares of the biotechnology company’s stock valued at $94,281,000 after acquiring an additional 221,261 shares in the last quarter. Ritholtz Wealth Management raised its position in shares of Axon Enterprise by 10,951.5% in the 3rd quarter. Ritholtz Wealth Management now owns 220,257 shares of the biotechnology company’s stock valued at $93,063,000 after purchasing an additional 218,264 shares during the last quarter. UNIVEST FINANCIAL Corp acquired a new stake in Axon Enterprise in the 3rd quarter worth approximately $12,961,000. NBH Bank boosted its stake in Axon Enterprise by 5,493.8% in the 3rd quarter. NBH Bank now owns 10,908 shares of the biotechnology company’s stock worth $4,609,000 after purchasing an additional 10,713 shares in the last quarter. Finally, First Command Advisory Services Inc. boosted its stake in Axon Enterprise by 10,431.1% in the 3rd quarter. First Command Advisory Services Inc. now owns 7,793 shares of the biotechnology company’s stock worth $3,293,000 after purchasing an additional 7,719 shares in the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have weighed in on AXON. Morgan Stanley boosted their target price on shares of Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. UBS Group raised their price target on shares of Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. The Goldman Sachs Group lowered their price objective on shares of Axon Enterprise from $715.00 to $675.00 and set a “buy” rating for the company in a research note on Monday, September 21st. Barclays lowered their price objective on shares of Axon Enterprise from $688.00 to $507.00 and set an “overweight” rating for the company in a research note on Monday. Finally, Raymond James Financial set a $675.00 price objective on shares of Axon Enterprise in a report on Thursday, October 15th. Thirteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $612.18.

Top Axon Enterprise Stories

Here are a few of the latest stories about AXON:

• Positive Sentiment: Axon’s integrated public-safety hardware and software ecosystem, along with continued revenue growth, are cited as reasons it could remain a long-term growth company despite its 2026 share-price decline. 3 Superior Growth Stocks That Can Outperform for the Next 10 Years
• Neutral Sentiment: Axon is investing $1.2 billion for a 37% stake in drone maker Skydio and will distribute its products to U.S. public-safety customers. The deal could broaden Axon’s offering, but its sizeable cost makes the investment a factor for investors to weigh. Axon invests $1.2B into Skydio and becomes its U.S. public safety distributor
• Negative Sentiment: Several law firms have announced investigations into potential securities-law claims related to Axon’s earnings report. These are allegations under investigation, not findings of wrongdoing, but add a source of uncertainty for investors. Levi & Korsinsky investor investigation notice

Insider Buying and Selling at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the sale, the chief executive officer directly owned 3,118,012 shares of the company’s stock, valued at $1,587,036,927.88. This represents a 0.32% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the stock in a transaction on Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the sale, the president owned 296,974 shares in the company, valued at $170,590,774.82. The trade was a 5.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 37,397 shares of company stock valued at $21,234,034. 4.20% of the stock is owned by corporate insiders.

Axon Enterprise Trading Up 4.3%

Shares of NASDAQ:AXON opened at $315.42 on Thursday. Axon Enterprise, Inc has a 52-week low of $291.45 and a 52-week high of $665.07. The stock has a market cap of $25.68 billion, a price-to-earnings ratio of 101.10, a PEG ratio of 5.75 and a beta of 1.48. The company has a quick ratio of 2.60, a current ratio of 3.00 and a debt-to-equity ratio of 0.76. The business has a 50-day moving average price of $426.24 and a 200-day moving average price of $470.65.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). The firm had revenue of $908.55 million for the quarter, compared to analyst estimates of $934.33 million. Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The company’s revenue for the quarter was up 27.8% compared to the same quarter last year. During the same period last year, the firm earned $1.17 EPS. Equities analysts predict that Axon Enterprise, Inc will post 2.10 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.